Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants

ABSTRACT OBJECTIVE To evaluate the prevalence of reports of symptoms of COVID-19 among individuals with and without antibodies and identify those with greater capability to predict the presence of antibodies against SARS-CoV-2. METHODS The study uses data collected in phases 5 to 8 of Epicovid-19-RS. The presence of antibodies against SARS-CoV-2 was evaluated by a rapid test. The occurrence of cough, fever, palpitations, sore throat, difficulty breathing, changes in taste and smell, vomiting, diarrhea, body pain, shaking, and headache since March 2020 was also evaluated. Then, the capability to predict the evaluated symptoms concerning the presence of antibodies was calculated. RESULTS A total of 18,000 individuals were interviewed and 181 had antibodies against COVID-19 in phases 5 to 8. The proportion of asymptomatic individuals was 19.9% among participants with antibodies and 49.7% among those without antibodies. All symptoms were reported more frequently by individuals with antibodies. The division of the prevalence of symptoms among individuals with antibodies by the prevalence among individuals without antibodies showed the following prevalence ratios: for changes in smell or taste (9.1), fever (4.2), tremors (3.9), breathing difficulty (3.2) and cough (2.8 times). Anosmia and fever were the symptoms with a greater capability to predict the presence of antibodies. CONCLUSION The prevalence of symptoms was higher among individuals with antibodies against SARS-CoV-2. The proportion of asymptomatic individuals was low. Altered smell or taste and fever were the symptoms that most predict the presence of antibodies. These results can help to identify probable cases, contributing to the clinical diagnosis and screening of patients for testing and isolation guidance in positive cases, especially in scenarios of the scarcity of diagnostic COVID-19 tests.

Saved in:
Bibliographic Details
Main Authors: Mesenburg,Marilia Arndt, Hallal,Pedro Curi, Menezes,Ana Maria Baptista, Barros,Aluísio J D, Horta,Bernardo Lessa, Hartwig,Fernando Pires, Jacques,Nadege, Pellanda,Lucia Campos, Zelmanowicz,Alice de Medeiros, Vergani,Daiane Oliveira Pereira, Ries,Edi Franciele, Harter,Jenifer, Martínez-Mesa,Jeovany, Carneiro,Marcelo, Estima,Sonara Lucia, Heck,Thiago Gomes, Silveira,Mariangela Freitas da
Format: Digital revista
Language:English
Published: Faculdade de Saúde Pública da Universidade de São Paulo 2021
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102021000100268
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-89102021000100268
record_format ojs
spelling oai:scielo:S0034-891020210001002682021-11-18Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participantsMesenburg,Marilia ArndtHallal,Pedro CuriMenezes,Ana Maria BaptistaBarros,Aluísio J DHorta,Bernardo LessaHartwig,Fernando PiresJacques,NadegePellanda,Lucia CamposZelmanowicz,Alice de MedeirosVergani,Daiane Oliveira PereiraRies,Edi FrancieleHarter,JeniferMartínez-Mesa,JeovanyCarneiro,MarceloEstima,Sonara LuciaHeck,Thiago GomesSilveira,Mariangela Freitas da COVID-19 Signs and Symptoms Symptoms Hierarchy COVID-19 Serological Testing Predictive Value of Tests Seroepidemiologic Studies ABSTRACT OBJECTIVE To evaluate the prevalence of reports of symptoms of COVID-19 among individuals with and without antibodies and identify those with greater capability to predict the presence of antibodies against SARS-CoV-2. METHODS The study uses data collected in phases 5 to 8 of Epicovid-19-RS. The presence of antibodies against SARS-CoV-2 was evaluated by a rapid test. The occurrence of cough, fever, palpitations, sore throat, difficulty breathing, changes in taste and smell, vomiting, diarrhea, body pain, shaking, and headache since March 2020 was also evaluated. Then, the capability to predict the evaluated symptoms concerning the presence of antibodies was calculated. RESULTS A total of 18,000 individuals were interviewed and 181 had antibodies against COVID-19 in phases 5 to 8. The proportion of asymptomatic individuals was 19.9% among participants with antibodies and 49.7% among those without antibodies. All symptoms were reported more frequently by individuals with antibodies. The division of the prevalence of symptoms among individuals with antibodies by the prevalence among individuals without antibodies showed the following prevalence ratios: for changes in smell or taste (9.1), fever (4.2), tremors (3.9), breathing difficulty (3.2) and cough (2.8 times). Anosmia and fever were the symptoms with a greater capability to predict the presence of antibodies. CONCLUSION The prevalence of symptoms was higher among individuals with antibodies against SARS-CoV-2. The proportion of asymptomatic individuals was low. Altered smell or taste and fever were the symptoms that most predict the presence of antibodies. These results can help to identify probable cases, contributing to the clinical diagnosis and screening of patients for testing and isolation guidance in positive cases, especially in scenarios of the scarcity of diagnostic COVID-19 tests.info:eu-repo/semantics/openAccessFaculdade de Saúde Pública da Universidade de São PauloRevista de Saúde Pública v.55 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102021000100268en10.11606/s1518-8787.2021055004030
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Mesenburg,Marilia Arndt
Hallal,Pedro Curi
Menezes,Ana Maria Baptista
Barros,Aluísio J D
Horta,Bernardo Lessa
Hartwig,Fernando Pires
Jacques,Nadege
Pellanda,Lucia Campos
Zelmanowicz,Alice de Medeiros
Vergani,Daiane Oliveira Pereira
Ries,Edi Franciele
Harter,Jenifer
Martínez-Mesa,Jeovany
Carneiro,Marcelo
Estima,Sonara Lucia
Heck,Thiago Gomes
Silveira,Mariangela Freitas da
spellingShingle Mesenburg,Marilia Arndt
Hallal,Pedro Curi
Menezes,Ana Maria Baptista
Barros,Aluísio J D
Horta,Bernardo Lessa
Hartwig,Fernando Pires
Jacques,Nadege
Pellanda,Lucia Campos
Zelmanowicz,Alice de Medeiros
Vergani,Daiane Oliveira Pereira
Ries,Edi Franciele
Harter,Jenifer
Martínez-Mesa,Jeovany
Carneiro,Marcelo
Estima,Sonara Lucia
Heck,Thiago Gomes
Silveira,Mariangela Freitas da
Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
author_facet Mesenburg,Marilia Arndt
Hallal,Pedro Curi
Menezes,Ana Maria Baptista
Barros,Aluísio J D
Horta,Bernardo Lessa
Hartwig,Fernando Pires
Jacques,Nadege
Pellanda,Lucia Campos
Zelmanowicz,Alice de Medeiros
Vergani,Daiane Oliveira Pereira
Ries,Edi Franciele
Harter,Jenifer
Martínez-Mesa,Jeovany
Carneiro,Marcelo
Estima,Sonara Lucia
Heck,Thiago Gomes
Silveira,Mariangela Freitas da
author_sort Mesenburg,Marilia Arndt
title Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
title_short Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
title_full Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
title_fullStr Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
title_full_unstemmed Prevalence of symptoms of COVID-19 in the state of Rio Grande do Sul: results of a population-based study with 18,000 participants
title_sort prevalence of symptoms of covid-19 in the state of rio grande do sul: results of a population-based study with 18,000 participants
description ABSTRACT OBJECTIVE To evaluate the prevalence of reports of symptoms of COVID-19 among individuals with and without antibodies and identify those with greater capability to predict the presence of antibodies against SARS-CoV-2. METHODS The study uses data collected in phases 5 to 8 of Epicovid-19-RS. The presence of antibodies against SARS-CoV-2 was evaluated by a rapid test. The occurrence of cough, fever, palpitations, sore throat, difficulty breathing, changes in taste and smell, vomiting, diarrhea, body pain, shaking, and headache since March 2020 was also evaluated. Then, the capability to predict the evaluated symptoms concerning the presence of antibodies was calculated. RESULTS A total of 18,000 individuals were interviewed and 181 had antibodies against COVID-19 in phases 5 to 8. The proportion of asymptomatic individuals was 19.9% among participants with antibodies and 49.7% among those without antibodies. All symptoms were reported more frequently by individuals with antibodies. The division of the prevalence of symptoms among individuals with antibodies by the prevalence among individuals without antibodies showed the following prevalence ratios: for changes in smell or taste (9.1), fever (4.2), tremors (3.9), breathing difficulty (3.2) and cough (2.8 times). Anosmia and fever were the symptoms with a greater capability to predict the presence of antibodies. CONCLUSION The prevalence of symptoms was higher among individuals with antibodies against SARS-CoV-2. The proportion of asymptomatic individuals was low. Altered smell or taste and fever were the symptoms that most predict the presence of antibodies. These results can help to identify probable cases, contributing to the clinical diagnosis and screening of patients for testing and isolation guidance in positive cases, especially in scenarios of the scarcity of diagnostic COVID-19 tests.
publisher Faculdade de Saúde Pública da Universidade de São Paulo
publishDate 2021
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102021000100268
work_keys_str_mv AT mesenburgmariliaarndt prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT hallalpedrocuri prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT menezesanamariabaptista prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT barrosaluisiojd prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT hortabernardolessa prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT hartwigfernandopires prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT jacquesnadege prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT pellandaluciacampos prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT zelmanowiczalicedemedeiros prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT verganidaianeoliveirapereira prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT riesedifranciele prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT harterjenifer prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT martinezmesajeovany prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT carneiromarcelo prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT estimasonaralucia prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT heckthiagogomes prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
AT silveiramariangelafreitasda prevalenceofsymptomsofcovid19inthestateofriograndedosulresultsofapopulationbasedstudywith18000participants
_version_ 1756379490893692928